Why does polycythemia often occur in individuals with Chronic Obstructive Pulmonary Disease (COPD)?

A. Mild hypertension can be a cause or a consequence of renal disease, but it is not a specific symptomatic marker for Stage 1. At this early stage, the compensatory mechanisms of the remaining functional nephrons usually prevent overt clinical manifestations of elevated blood pressure. Most patients with a glomerular filtration rate above 90 remain asymptomatic regarding vascular changes.

B. Usually no symptoms are seen at this stage because the kidneys possess a significant functional reserve that masks early damage. Stage 1 is defined by a normal or high glomerular filtration rate (≥ 90 mL/min) with evidence of kidney damage, such as albuminuria. Most individuals are unaware of the condition until it is incidentally discovered during routine laboratory screenings.

C. Hyperphosphatemia typically does not manifest until the later stages of chronic kidney disease, usually Stage 4 or 5. In Stage 1, the kidneys are still sufficiently capable of excreting excess phosphate and maintaining mineral balance through hormonal regulation. Electrolyte imbalances signify a much more advanced degree of nephron loss and a severe decline in filtering capacity.

D. Anemia in chronic kidney disease is primarily caused by a deficiency in erythropoietin production, which generally occurs as the disease progresses to Stage 3. In the initial stage, the peritubular cells are usually still functional enough to stimulate adequate red blood cell production. Clinical anemia is therefore not an expected finding during the very early onset of renal impairment.

A. An estimated glomerular filtration rate (eGFR) between 30 and 59 mL/min signifies Stage 3 chronic kidney disease, indicating a moderate reduction in renal function. At this level, patients often begin to manifest complications such as secondary hyperparathyroidism, anemia, and early bone disease. It represents a more advanced decline than Stage 2.

B. The eGFR range of 15 to 29 mL/min is classified as Stage 4 chronic kidney disease, which is a severe reduction in kidney function. Patients at this stage are typically being prepared for renal replacement therapy, such as dialysis or transplantation. This reflects significant nephron loss and a high risk for systemic metabolic acidosis.

C. Stage 2 chronic kidney disease is defined by an eGFR of 60 to 89 mL/min, representing a mild reduction in renal filtration. To meet the diagnostic criteria for CKD at this stage, there must also be evidence of structural kidney damage, such as persistent albuminuria. It indicates the early stages of progressive renal impairment.

D. An eGFR ≥90 mL/min is considered Stage 1 chronic kidney disease if there is concurrent evidence of kidney damage, such as proteinuria or structural abnormalities. This value represents normal or high filtration capacity. In the absence of other markers of damage, this range is simply considered normal physiological renal function for most adults.